Revenue Summary of Vicarious Surgical Inc.

Vicarious Surgical Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
Vicarious Surgical Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down -100.0% from previous quarter.
Vicarious Surgical Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
Vicarious Surgical Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
Vicarious Surgical Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
Vicarious Surgical Inc. reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Vicarious Surgical Inc. (2023 - 2019)

Name	Revenue	Revenue Difference
Abbott Laboratories	40.1 Billion USD	100.0%
Allurion Technologies Inc.	53.46 Million USD	100.0%
Artivion, Inc.	354 Million USD	100.0%
Avanos Medical, Inc.	673.3 Million USD	100.0%
Butterfly Network, Inc.	65.9 Million USD	100.0%
Butterfly Network, Inc.	65.9 Million USD	100.0%
Bio-Rad Laboratories, Inc.	2.67 Billion USD	100.0%
Boston Scientific Corporation	14.24 Billion USD	100.0%
Perspective Therapeutics, Inc.	7.1 Million USD	100.0%
CONMED Corporation	1.24 Billion USD	100.0%
Edwards Lifesciences Corporation	6 Billion USD	100.0%
Paragon 28, Inc.	216.38 Million USD	100.0%
Glaukos Corporation	314.71 Million USD	100.0%
Globus Medical, Inc.	1.56 Billion USD	100.0%
Inspire Medical Systems, Inc.	624.79 Million USD	100.0%
Integer Holdings Corporation	1.59 Billion USD	100.0%
Medtronic plc	32.36 Billion USD	100.0%
Nevro Corp.	425.17 Million USD	100.0%
Owlet, Inc.	54.01 Million USD	100.0%
Penumbra, Inc.	1.05 Billion USD	100.0%
Smith & Nephew plc	5.54 Billion USD	100.0%
Sonendo, Inc.	43.86 Million USD	100.0%
STERIS plc	5.13 Billion USD	100.0%
Stryker Corporation	20.49 Billion USD	100.0%
Vapotherm, Inc.	68.66 Million USD	100.0%
Zimmer Biomet Holdings, Inc.	7.39 Billion USD	100.0%